Literature DB >> 15065094

Prostatic intraepithelial neoplasia and intestinal metaplasia in prostates of probasin-RAS transgenic mice.

Alexis Scherl1, Jiu-Feng Li, Robert D Cardiff, Nicole Schreiber-Agus.   

Abstract

BACKGROUND: Activation of the RAS pathway has been implicated in the pathogenesis of many types of human cancers, including prostate cancer. Here we employed a transgenic approach to assess the potential contribution of RAS to prostate carcinogenesis.
METHODS: Probasin-RAS (Pb-RAS) transgenic mice were generated and shown to express high levels of activated RAS in the prostate lobes. Transgenic prostates were compared to normal controls by histology and immunohistochemistry with relevant markers.
RESULTS: Pb-RAS transgenic prostates exhibit neoplastic changes including low-grade prostatic intraepithelial neoplasia, and metaplastic changes towards an intestinal goblet cell phenotype. The finding of high levels of the goblet cell-specific peptide Itf/Tff3 in these transgenic prostates is in accordance with recent microarray studies showing that ITF/TFF3 is upregulated in human prostate cancer samples.
CONCLUSIONS: The Pb-RAS mouse model could be useful for elucidating the early events in prostate carcinogenesis, as well as for studying the mechanisms and potential prostate cancer relevance of intestinal metaplasia. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15065094     DOI: 10.1002/pros.20020

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  19 in total

1.  A constitutively activated form of the p110beta isoform of PI3-kinase induces prostatic intraepithelial neoplasia in mice.

Authors:  Sang Hyun Lee; George Poulogiannis; Saumyadipta Pyne; Shidong Jia; Lihua Zou; Sabina Signoretti; Massimo Loda; Lewis Clayton Cantley; Thomas M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  In vitro and in vivo model systems used in prostate cancer research.

Authors:  David Cunningham; Zongbing You
Journal:  J Biol Methods       Date:  2015

3.  SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia.

Authors:  Helen B Pearson; Pedro A Perez-Mancera; Lukas E Dow; Andrew Ryan; Pierre Tennstedt; Debora Bogani; Imogen Elsum; Andy Greenfield; David A Tuveson; Ronald Simon; Patrick O Humbert
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

4.  Transgenic expression of polyomavirus middle T antigen in the mouse prostate gives rise to carcinoma.

Authors:  Sang Hyun Lee; Shidong Jia; Yanni Zhu; Tamara Utermark; Sabina Signoretti; Massimo Loda; Brian Schaffhausen; Thomas M Roberts
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

5.  Incidence of Mucinous Metaplasia in the Prostate of FVB/N Mice (Mus musculus).

Authors:  Leena Latonen; Paula Kujala; Tapio Visakorpi
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

Review 6.  From genomics to functions: preclinical mouse models for understanding oncogenic pathways in prostate cancer.

Authors:  Chuan Yu; Kevin Hu; Daniel Nguyen; Zhu A Wang
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

Review 7.  Drug discovery in prostate cancer mouse models.

Authors:  Kenneth C Valkenburg; Kenneth J Pienta
Journal:  Expert Opin Drug Discov       Date:  2015-06-01       Impact factor: 6.098

Review 8.  Current mouse and cell models in prostate cancer research.

Authors:  Xinyu Wu; Shiaoching Gong; Pradip Roy-Burman; Peng Lee; Zoran Culig
Journal:  Endocr Relat Cancer       Date:  2013-06-24       Impact factor: 5.678

9.  Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures.

Authors:  Xiaoming Ju; Adam Ertel; Mathew C Casimiro; Zuoren Yu; Hui Meng; Peter A McCue; Rhonda Walters; Paolo Fortina; Michael P Lisanti; Richard G Pestell
Journal:  Cancer Res       Date:  2012-11-30       Impact factor: 12.701

10.  Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer.

Authors:  Ran-Ju Kim; Soo-Rim Kim; Kyung-Jin Roh; Sang-Bum Park; Jeong-Ran Park; Kyung-Sun Kang; Gu Kong; Binwu Tang; Yu-An Yang; Ethan A Kohn; Lalage M Wakefield; Jeong-Seok Nam
Journal:  Cancer Lett       Date:  2009-07-07       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.